TABLE 3.
Recurrence rates, second lung primary tumors, and extrathoracic primary tumors and survivorship enrollment
| Non-TSP | TSP | |
|---|---|---|
| Recurrence | [2787] | [1153] |
| Yes | 549 | 80 |
|
| ||
| Recurrence location (n = 629) | ||
| Distant | 298 | 41 |
| Locoregional | 153 | 25 |
| Distant + locoregional | 98 | 14 |
|
| ||
| Second lung primary malignancy | [2794] | [1146] |
| Yes | 322 | 136 |
|
| ||
| Clinical stage of second lung primary (n = 458) | ||
| IA | 262 | 112 |
| IB | 11 | 5 |
| II | 16 | 3 |
| IIIA | 16 | 6 |
| IIIB/C/IV | 17 | 10 |
|
| ||
| Treatment of second lung primary | ||
| Local (surgery or radiation) | 277 | 118 |
| Local and systemic | 19 | 6 |
| Systemic | 10 | 6 |
| Observation | 16 | 6 |
|
| ||
| Second extrathoracic malignancy | [2817] | [1123] |
| Yes | 225 | 69 |
|
| ||
| Site of second extrathoracic malignancy (n = 294) | ||
| Prostate/kidney/urologic | 48 | 17 |
| Breast | 33 | 12 |
| Thyroid | 29 | 6 |
| Other | 115 | 35 |
Each outcome was analyzed separately with regards to TSP enrollment at the time of outcome; thus the number of patients in TSP is different depending on outcome. [ ] Indicates total patients in TSP or non-TSP analyzed for each outcome. TSP, Thoracic Survivorship Program